Navigation Links
Breast Cancer Patients Sent to Australia for Treatment
Post Your Comments:
(Date:11/21/2008)...stories of living with HIV/AIDS , , WASHING...e leading cause of death for African American wome...ed by 30 percent per year if all HIV infected pers... changes to limit the spread of the disease. , ...uilt.org ) was featured this week at the 2008 Nati...
(Date:11/21/2008)...er Safety, Inc., located in,Pittsburgh PA, and a ...ucts,provider, is countering what it believes are...tory Protection USA (formerly Bacou-Dalloz USA) of...7000 SCBA (Self-Contained Breathing,Apparatus) us...respect for intellectual property rights, but,bel...
(Date:11/21/2008)...ted at the 61st Annual Scientific Meeting of the G...ade; (sitagliptin), a diabetes medicine from Merck...r levels in elderly patients with type 2 diabetes ...d sugar). In this study of 206 patients aged 65 to...n either the JANUVIA or the placebo groups. Advanc...
(Date:11/21/2008)...pport Children Affected by HIV/AIDS in New Jersey ...ewswire/ -- Today, more than 800 local Roche emplo... Children,s Walk to raise funds to support child...y and Africa. Employees who volunteer for the 5K W...ey, collect donations for their efforts, and Roche...
Breaking Medicine News(10 mins):Health News:Southern AIDS Living Quilt Raises Awareness at National HIV Summit 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 2Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 3Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 4Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 5Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 6Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 7Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 8Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 9Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 10Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 11Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 12Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 13Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 14Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 15Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 16Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 17Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 18Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 19Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 20Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 21Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 22Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 23Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 24Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 25Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 26Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 27Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 28Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 29Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 30Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 31Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 32Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 33Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 34
...ex for money or drugs, reveals a large representat... Sexually Transmitted// Infections. The authors ...dolescents taking part in a study tracking the lon...e country (National Longitudinal Study of Adolesce...
...nts died and nearly 2000 suffered 'moderate to sev...ed and given in the hospitals.// These are just a ...e recorded in all 173 NHS trusts in England during... This information was published by the Healthcare ...
...hat in a new project they've begun to draw out a n...some people// are susceptible or resistant to cert...sis of the project that is being undertaken by the...as released yesterday, the 10th August, and it is ...
...l University have been granted a 'mercy attempt', ...lear their respective// examinations. The Faculty ...medical university on Friday. Rules so far have a...ts to clear each professional. Although an examina...
Other Medicine News:Health News:More than 3% of US Teens Have Exchanged Sex for Money or Drugs 2Health News:Researchers from Emory University Undertake A New Genetic Mapping 2
(Date:11/18/2008)... Visit www.christmasseals.org to learn more, ma... , WASHINGTON, Nov. 17 /PRNewswire-USNewswire...mail this month, courtesy of the American Lung Ass... of an annual fundraising tradition dating back to...quer tuberculosis. , , "Most Americans al...
(Date:11/18/2008)... LANSDOWNE, Va., Nov. 18 /PRNewswire-USNewswire/ ...sts gathered at a November national forum to consi...ca,s public health and national economy from outbr...er announced today. , , Among those innovat...on every American kitchen table that detects highl...
(Date:11/18/2008)... Randomized study will enroll newly diagnosed, el.... 18 Celator Pharmaceuticals today... in a randomized Phase 2 clinical study of CPX-351...atients with newly diagnosed acute myeloid leukemi... by Eric Feldman, MD at the Weill Medical College...
(Date:11/13/2008)... , ASPS Study Suggests Nutritional Supplements P... Identifying,malnutriti...seeking body,contouring will significantly decreas..., improve scar quality and boost patient energy le...f Plastic and Reconstructive,Surgery(R), the offic...
Breaking Medicine Technology:American Lung Association Celebrates 101st Annual Christmas Seals Campaign 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 1Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 3Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 4Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 5Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 6Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 7Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 8Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 9BioMS Medical announces first quarter 2008 results 5461 1BioMS Medical announces first quarter 2008 results 5461 2BioMS Medical announces first quarter 2008 results 5461 3BioMS Medical announces first quarter 2008 results 5461 4BioMS Medical announces first quarter 2008 results 5461 5WorldHeart Announces Possible Delisting Action by NASDAQ 19543 1WorldHeart Announces Possible Delisting Action by NASDAQ 19543 2WorldHeart Announces Possible Delisting Action by NASDAQ 19543 3Statement from Larry Minnix President 26 CEO American Association of Homes and Services for the Aging On the Government Accountability Offices 28G 19538 1
...RE)--Apr 18, 2007 -,AVEO Pharmaceuticals, Inc., a ... and development of novel, targeted cancer medicin...in-mouse (HIM) tissue,transgenic cancer model syst...man tumors that develop over time in mice from pri...tists, for the first,time, to generate and study i...
...r Treatment,Decisions , SALT LAKE CITY, UT, April ... target="_blank" href=,"http://www.myriad.com/">ww...tudies for a new technology that might be used to,...mor, on Monday,April 16, 2007 at the annual meeti... (AACR) in Los Angeles, California. This work,coul...
Other Medicine Technology:Novel Human Tissue Transgenic Cancer Model May Offer Significant,Advance Toward Accurately Modeling Human Cancer 2Novel Human Tissue Transgenic Cancer Model May Offer Significant,Advance Toward Accurately Modeling Human Cancer 3Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3
Slender 4.5 mm long rounded platform. Serrated handle with polished finish.
Solid lower plate with outside width 28 mm. Open upper plate. Serrated handle with locking thumb screw and polished finish. Right.
Titanium. The popular Utrata Capsulorhexis Forceps in a titanium version. The ultra-fine tips are designed with an iris stop and angled platform tips for grasping delicate capsule.
McPherson handle. 45 degree angled shafts. Manufactured in titanium.
Medicine Products: